Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Atezolizumab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IMvigor011 Shows Positive Results, Signatera Predicts Benefit
    IMvigor011 Shows Positive Results, Signatera Predicts Benefit

    18 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250818904141/en/IMvigor011-Bladder-Cancer-Trial-Achieves-Positive-Results-with-Signatera-Strongly-Predicting-Adjuvant-Immunotherapy-Benefit

    BUSINESSWIRE
    18 Aug 2025
    Share Share
    Genentech’s Biologics Tecentriq Receives Suppl Approval in US
    Genentech’s Biologics Tecentriq Receives Suppl Approval in US

    18 Aug 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761347

    FDA
    18 Aug 2025
    Share Share
    Xilio Therapeutics Updates Pipeline, Business, Q2 2025 Financials
    Xilio Therapeutics Updates Pipeline, Business, Q2 2025 Financials

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133362/0/en/Xilio-Therapeutics-Announces-Pipeline-and-Business-Updates-and-Second-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share
    Pilatus, Roche to Test PLT012 in Hepatocellular Carcinoma
    Pilatus, Roche to Test PLT012 in Hepatocellular Carcinoma

    13 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250813741707/en/Pilatus-Biosciences-Announces-Clinical-Trial-Collaboration-with-Roche-to-Evaluate-PLT012-in-First-in-Human-Study-in-Hepatocellular-Carcinoma

    BUSINESSWIRE
    13 Aug 2025
    Share Share
    Exelixis: Zanzalintinib Combo Boosts OS in Colorectal Cancer
    Exelixis: Zanzalintinib Combo Boosts OS in Colorectal Cancer

    22 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250622399674/en/Exelixis-Announces-Zanzalintinib-in-Combination-with-an-Immune-Checkpoint-Inhibitor-Improved-Overall-Survival-in-STELLAR-303-Phase-3-Pivotal-Trial-in-Patients-with-Metastatic-Colorectal-Cancer

    BUSINESSWIRE
    22 Jun 2025
    Share Share
    Zepzelca and Atezolizumab Combo Granted FDA Priority Review
    Zepzelca and Atezolizumab Combo Granted FDA Priority Review

    10 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zepzelca-lurbinectedin-and-atezolizumab-tecentriq-combination-granted-us-fda-priority-review-for-first-line-maintenance-treatment-of-extensive-stage-small-cell-lung-cancer-302477581.html

    PR NEWSWIRE
    10 Jun 2025
    Share Share